Cargando…

Exosomes and Hepatocellular Carcinoma: From Bench to Bedside

As hepatocellular carcinoma (HCC) usually occurs in the background of cirrhosis, which is an end-stage form of liver diseases, treatment options for advanced HCC are limited, due to poor liver function. The exosome is a nanometer-sized membrane vesicle structure that originates from the endosome. Ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sasaki, Reina, Kanda, Tatsuo, Yokosuka, Osamu, Kato, Naoya, Matsuoka, Shunichi, Moriyama, Mitsuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471845/ https://www.ncbi.nlm.nih.gov/pubmed/30897788 http://dx.doi.org/10.3390/ijms20061406

Ejemplares similares

Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
por: Sasaki, Reina, et al.
Publicado: (2018)

Molecular Changes in Relation to Alcohol Consumption and Hepatocellular Carcinoma
por: Sasaki-Tanaka, Reina, et al.
Publicado: (2022)

Exosomes and circular RNAs: promising partners in hepatocellular carcinoma from bench to bedside
por: Hu, Mengyuan, et al.
Publicado: (2023)

The androgen receptor as an emerging target in hepatocellular carcinoma
por: Kanda, Tatsuo, et al.
Publicado: (2015)

Hepatitis C Virus and Hepatocellular Carcinoma
por: Kanda, Tatsuo, et al.
Publicado: (2013)

Superinfection of hepatitis A virus in hepatocytes infected with hepatitis B virus
por: Win, Nan Nwe, et al.
Publicado: (2019)

Suppressors of Cytokine Signaling and Hepatocellular Carcinoma
por: Masuzaki, Ryota, et al.
Publicado: (2022)

Exosomes in multiple myeloma: from bench to bedside
por: Menu, Eline, et al.
Publicado: (2022)

Noninvasive Assessment of Liver Fibrosis: Current and Future Clinical and Molecular Perspectives
por: Masuzaki, Ryota, et al.
Publicado: (2020)

Persistent Hepatic Inflammation Plays a Role in Hepatocellular Carcinoma After Sustained Virological Response in Patients with HCV Infection
por: Nirei, Kazushige, et al.
Publicado: (2018)

Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside
por: Siracusano, Gabriel, et al.
Publicado: (2020)

Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside
por: Guan, Ming-Cheng, et al.
Publicado: (2021)

Prior hepatitis B virus infection as a co-factor of chronic hepatitis C patient survival after resection of hepatocellular carcinoma
por: Midorikawa, Yutaka, et al.
Publicado: (2019)

Different Mechanisms of Action of Regorafenib and Lenvatinib on Toll-Like Receptor-Signaling Pathways in Human Hepatoma Cell Lines
por: Sasaki, Reina, et al.
Publicado: (2020)

Androgen Receptor Could Be a Potential Therapeutic Target in Patients with Advanced Hepatocellular Carcinoma
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma
por: Kanda, Tatsuo, et al.
Publicado: (2020)

Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review
por: Kanda, Tatsuo, et al.
Publicado: (2019)

Sepsis: From Bench to Bedside
por: Silva, Eliézer, et al.
Publicado: (2008)

Linagliptin: from bench to bedside
por: Doupis, John
Publicado: (2014)

Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection
por: Kanda, Tatsuo, et al.
Publicado: (2020)

Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside
por: Uddin, Md. Hafiz, et al.
Publicado: (2021)

Olutasidenib: from bench to bedside
por: Venugopal, Sangeetha, et al.
Publicado: (2023)

Endogenous Lipid Carriers—Bench-to-Bedside Roadblocks in Production and Drug Loading of Exosomes
por: Richards, Terjahna, et al.
Publicado: (2023)

Research in Sickle Cell Disease: From Bedside to Bench to Bedside
por: Salinas Cisneros, Gabriel, et al.
Publicado: (2021)

MEK and the inhibitors: from bench to bedside
por: Akinleye, Akintunde, et al.
Publicado: (2013)

Variable ventilation from bench to bedside
por: Huhle, Robert, et al.
Publicado: (2016)

Biology of Cholangiocytes: From Bench to Bedside
por: Yoo, Kyo-Sang, et al.
Publicado: (2016)

CDG Therapies: From Bench to Bedside
por: Brasil, Sandra, et al.
Publicado: (2018)

Dystonia and Cerebellum: From Bench to Bedside
por: Morigaki, Ryoma, et al.
Publicado: (2021)

Alcohol in Psoriasis—From Bench to Bedside
por: Szentkereszty-Kovács, Zita, et al.
Publicado: (2021)

From bench to bedside
por: Verdant, Colin L
Publicado: (2012)

Cemiplimab and Cutaneous Squamous Cell Carcinoma: From Bench to Bedside
por: Goodman, D.T.
Publicado: (2022)

Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside
por: Sajid, Muhammad Imran, et al.
Publicado: (2020)

Cancer proteomics: from bench to bedside
por: Timms, J F
Publicado: (2008)

Indirect Calorimetry: From Bench to Bedside
por: Gupta, Riddhi Das, et al.
Publicado: (2017)

Drug addiction: from bench to bedside
por: Cheron, Julian, et al.
Publicado: (2021)

Bench and Bedside
por: Schmidt, Christian
Publicado: (2002)

Favipiravir Inhibits Hepatitis A Virus Infection in Human Hepatocytes
por: Sasaki-Tanaka, Reina, et al.
Publicado: (2022)

Molecular Mechanisms, Diagnosis and Treatments in Digestive Malignancy
por: Kanda, Tatsuo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1nva2f17vhm6c8gked9l2mgi3i